Does rosiglitazone adversely affect bone formation and bone mineral density in postmenopausal women?
Schwartz
Ann V
AV
Department of Epidemiology and Biostatistics, University of California San Francisco, 185 Berry Street, Suite 5700, San Francisco, CA 94107, USA. aschwartz@psg.ucsf.edu
Cummings
Steven R
SR